Antimicrobial polymers formed by bulk polyaddition
US-2016374335-A1 · Dec 29, 2016 · US
US10836864B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10836864-B2 |
| Application number | US-201715839410-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 12, 2017 |
| Priority date | Dec 12, 2017 |
| Publication date | Nov 17, 2020 |
| Grant date | Nov 17, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Techniques regarding killing of a pathogen with one or more ionene compositions having antimicrobial functionality are provided. For example, one or more embodiments can comprise a method, which can comprise contacting a Mycobacterium tuberculosis microbe with a chemical compound. The chemical compound can comprise an ionene unit. Also, the ionene unit can comprise a cation distributed along a molecular backbone. The ionene unit can have antimicrobial functionality. The method can further comprise electrostatically disrupting a membrane of the Mycobacterium tuberculosis microbe in response to the contacting.
Opening claim text (preview).
What is claimed is: 1. A method for inhibiting Mycobacterium tuberculosis , comprising: contacting a Mycobacterium tuberculosis microbe with a chemical compound, the chemical compound comprising an ionene unit, and the ionene unit comprising a cation distributed along a molecular backbone, wherein the ionene unit has antimicrobial functionality, wherein the molecular backbone is degradable, and wherein the chemical compound is characterized by the following structure: wherein X is the cation, wherein R is a hydrophobic functional group, wherein n is an integer greater than or equal to two and less than or equal to one thousand, and wherein L is a linkage group selected from the group consisting of an ester group and a carbonyl group; and electrostatically disrupting a membrane of the Mycobacterium tuberculosis microbe in response to the contacting. 2. The method of claim 1 , wherein the method further comprises: destabilizing the membrane through integration of the hydrophobic functional group into the membrane. 3. The method of claim 1 , wherein the cation is a nitrogen cation selected from the group comprising a protonated secondary amine cation, a protonated tertiary amine cation, a quaternary ammonium cation and an imidazolium cation. 4. The method of claim 3 , wherein the method further comprises: destabilizing the membrane through integration of the hydrophobic functional group into the membrane. 5. A method for inhibiting Mycobacterium tuberculosis , comprising: contacting a Mycobacterium tuberculosis microbe with a chemical compound, the chemical compound comprising an ionene unit, and the ionene unit comprising a cation distributed along a molecular backbone, wherein the ionene unit has antimicrobial functionality, wherein the molecular backbone is degradable, and wherein the chemical compound is characterized by the following structure: wherein X is the cation, wherein R is a hydrophobic functional group, wherein n is an integer greater than or equal to two and less than or equal to one thousand, and wherein L is a linkage group selected from the group consisting of: an alkyl group, aryl group, an alkenyl group, an aldehyde group, an ester group, a carboxyl group, and a carbonyl group; and electrostatically disrupting a membrane of the Mycobacterium tuberculosis microbe in response to the contacting. 6. The method of claim 5 , wherein the cation is a nitrogen cation selected from the group comprising a protonated secondary amine cation, a protonated tertiary amine cation, a quaternary ammonium cation and an imidazolium cation. 7. The method of claim 6 , wherein the method further comprises: destabilizing the membrane through integration of the hydrophobic functional group into the membrane. 8. The method of claim 5 , wherein the ionene unit has a chemical structure selected from the group consisting of: 9. A method for inhibiting Mycobacterium tuberculosis , comprising: contacting a Mycobacterium tuberculosis microbe with a chemical compound, the chemical compound comprising an ionene unit, and the ionene unit comprising a cation distributed along a molecular backbone, wherein the ionene unit has antimicrobial functionality, wherein the molecular backbone is degradable; and electrostatically disrupting a membrane of the Mycobacterium tuberculosis microbe in response to the contacting, wherein the ionene unit has a chemical structure selected from the group consisting of: wherein n is a first integer greater than or equal to one and less than or equal to one thousand, wherein m is a second integer greater than or equal to one and less than or equal to one thousand, wherein y is a third integer greater than or equal to one and less than or equal to one thousand, wherein x is a fourth integer greater than or equal to one and less than or equal to one thousand, and wherein ED 2000 is a poly(propylene glycol)-block-poly(ethylene glycol)-block-poly(propylene glycol) bis(2-aminopropyl ether) structure having a molecular weight greater than or equal to 1900 grams per mole and less than or equal to 2200 grams per mole.
for tuberculosis · CPC title
with a bicyclo ring system containing ten carbon atoms · CPC title
containing heterocyclic rings having nitrogen as a ring hetero atom · CPC title
Polyamines containing heterocyclic moieties in the main chain · CPC title
Quaternisation of polyamidoamines · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.